JD Health International Inc. filed a Next Day Disclosure Return with the Hong Kong Stock Exchange on 22 July 2026, confirming the cancellation of 21.54 million ordinary shares that had been repurchased between 15 May and 30 June 2026.

The cancellation cut the company’s issued share capital to 3.19 billion shares from 3.21 billion, representing a 0.67% reduction.

Repurchase prices for the cancelled shares ranged from HK$32.05 to HK$45.17 per share. Based on the disclosed volumes and prices, the volume-weighted average repurchase price is calculated at approximately HK$38.92, implying an aggregate consideration of about HK$838.77 million.

Following the share cancellation, the company reported no treasury shares. The disclosure was authorised by Director Dong Cao.